Radiation dose during percutaneous treatment of structural heart disease
| Autor: | J. Boland, Louis W. Wang, Dylan G. Wynne, David W.M. Muller, Bernard J. Love |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Pulmonary and Respiratory Medicine
Aortic valve Balloon Valvuloplasty Male medicine.medical_specialty Percutaneous Time Factors Heart disease Heart Diseases medicine.medical_treatment Coronary Angiography Radiation Dosage Left atrial appendage occlusion Transcatheter Aortic Valve Replacement Percutaneous Coronary Intervention Internal medicine Medicine Humans History Ancient Aged business.industry MitraClip Percutaneous coronary intervention Middle Aged medicine.disease Aortic valvuloplasty Surgery medicine.anatomical_structure Patent foramen ovale Cardiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | Heart, lungcirculation. 23(11) |
| ISSN: | 1444-2892 |
| Popis: | Background With the increased application of structural heart intervention techniques, there is concern over increasing radiation dose, especially during lengthy procedures. Methods We compared data from 91 consecutive single-vessel percutaneous coronary interventions, 69 patent foramen ovale closures, 25 atrial septal defect closures, 49 percutaneous transluminal mitral valvuloplasties, 57 balloon aortic valvuloplasties, 53 trans-catheter aortic valve implantations (TAVI), 21 left atrial appendage occlusions and 7 MitraClip ® procedures. Results The following fluoroscopy times and dose-area product (median, interquartile range) were recorded: patent foramen ovale closure (7.8, 5.3-10.9minutes; 16.9, 7.5-30.6 Gycm 2 ), atrial septal defect closure (10.1, 7.3-13minutes; 15.5, 11.6-30.5 Gycm 2 ), percutaneous transluminal mitral valvuloplasty (14.3, 11.4-24.2minutes; 37.4, 19.8-87.0 Gycm 2 ), balloon aortic valvuloplasty (8.4, 5.2-13.2minutes; 19.8, 10.2-30.0 Gycm 2 ), Edwards Sapien™ TAVI (24.0, 19.3-34.4minutes; 86.4, 64.0-111.4 Gycm 2 ), Medtronic CoreValve ® TAVI (19.4, 15.0-26.0minutes; 101.9, 52.6-143.2 Gycm 2 ), left atrial appendage occlusion (18.5, 15.7-29.1minutes; 84.1, 36.4-140.0 Gycm 2 ), Mitraclip ® procedures (37.2, 14.2-59.9minutes; 89.1, 26.2-118.7 Gycm 2 ), coronary angiography and single vessel percutaneous coronary intervention (6.6, 5.1-11.0minutes; 62.5, 37.0-95.8 Gycm 2 ). Conclusion For structural heart interventions, dose-area product was not significantly greater than for coronary angiography with single-vessel percutaneous coronary artery intervention. This should be reassuring to patients and staff attending prolonged structural heart interventions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect